DanielJeremyKassMD
Pulmonology • Pittsburgh, PACritical Care Medicine, Interstitial Lung Diseases, Pleural Disease
Assistant Professor, Medicine, University of Pittsburgh School of Medicine
Dr. Kass is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3459 5th Ave
# 628
Pittsburgh, PA 15213Phone+1 412-692-2210
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Pulmonary Disease and Critical Care Medicine, 2002 - 2005- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1999 - 2002
New York University School of MedicineClass of 1999
Certifications & Licensure
PA State Medical License 2009 - 2024
NY State Medical License 2000 - 2011
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Clinical Trials
- Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2003 Jan 01
- Dorothy P. and Richard P. Simmons Center for ILD Research Registry Start of enrollment: 2003 Oct 01
- Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2005 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- A Ramped Treadmlll Protocol Exercise Test Identifies Higher Ambulatory Oxygen Needs in IPF and COPD.Kristopher P Clark, Seyed Mehdi Nouraie, Kathleen O Lindell, Kevin F Gibson, Frank C Sciurba
Annals of the American Thoracic Society. 2024-11-20 - Design of a randomised controlled hybrid trial of nintedanib in patients with progressive myositis-associated interstitial lung disease.Rohit Aggarwal, Chester V Oddis, Daniel I Sullivan, Siamak Moghadam-Kia, Didem Saygin
BMC Pulmonary Medicine. 2024-10-30 - 3 citationsAmbient Ultrafine Particulate Matter and Clinical Outcomes in Fibrotic Interstitial Lung Disease.Gillian C Goobie, Provat K Saha, Christopher Carlsten, Kevin F Gibson, Kerri A Johannson
American Journal of Respiratory and Critical Care Medicine. 2024-05-01
Press Mentions
- National Initiatives to Prevent Myocardial Infarction and StrokeMarch 12th, 2021
He Saw ‘No Proof’ Closures Would Curb Virus. Now He Has De Blasio’s TrustMay 14th, 2020
Grant Support
- Methionine Aminopeptidase 2 In Pulmonary FibrosisNational Heart, Lung, And Blood Institute2010–2012
- Methionine Aminopeptidase 2 In Pulmonary FibrosisNational Heart, Lung, And Blood Institute2008–2010
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
